ARTAL GROUP S.A. Holdings

ARTAL GROUP S.A. is an investment fund managing more than 2.34B US dollars. The largest holdings include SPDR S&P Biotech ETF, Lexicon Pharmaceuticals and Mirati Therapeutics. In Q3 2022 the fund bought assets of total value of 463.2M US dollars and sold assets of total value of 266.81M US dollars.

$2.34B

portfolio value

+2.53%

quarter

-53.83%

1 year

-49.27%

3 years

-25.12%

5 years

ARTAL GROUP S.A. portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	87041000	94659000
Q2 2016	102462000	130709000
Q3 2016	89952000	32817000
Q4 2016	119702000	158238000
Q1 2017	135759000	53500000
Q2 2017	100350000	86377000
Q3 2017	60544000	107234000
Q4 2017	22656000	85331000
Q1 2018	401961000	123627000
Q2 2018	373309000	3334710000
Q3 2018	186271000	1071644000
Q4 2018	165333000	158186000
Q1 2019	371383000	11101000
Q2 2019	370705000	217075000
Q3 2019	743466000	548480000
Q4 2019	398813000	176520000
Q1 2020	330254000	101874000
Q2 2020	608607000	48064000
Q3 2020	681744000	466715000
Q4 2020	1173020000	84591000
Q1 2021	658949000	468087000
Q2 2021	355401000	428256000
Q3 2021	419959000	329554000
Q4 2021	128703000	89737000
Q1 2022	29345000	358952000
Q2 2022	5483000	175483000
Q3 2022	463200000	266808000

ARTAL GROUP S.A. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
SPDR S&P Biotech ETF Portfolio share: 16.93% Portfolio value: 396.6M Avg. open price: $84.48 Current price: $82.88 P/L: -1.89% N/A Q3 2022	call	16.93%	396.6M	$84.48	$82.88	-1.89%	N/A Q3 2022
Biotechnology Lexicon Pharmaceuticals, Inc. Portfolio share: 9.20% Portfolio value: 215.46M Avg. open price: $2.37 Current price: $2.16 P/L: -8.91% Bought +26.13% shares Q3 2022	share	9.20%	215.46M	$2.37	$2.16	-8.91%	Bought +26.13% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 3.95% Portfolio value: 92.53M Avg. open price: $155.75 Current price: $92.75 P/L: -40.45% Bought +20.45% shares Q3 2022	share	3.95%	92.53M	$155.75	$92.75	-40.45%	Bought +20.45% shares Q3 2022
Biotechnology BeiGene, Ltd. Portfolio share: 3.74% Portfolio value: 87.63M Avg. open price: $134.98 Current price: $188.71 P/L: +39.80% Sold -2.26% shares Q2 2022	share	3.74%	87.63M	$134.98	$188.71	+39.80%	Sold -2.26% shares Q2 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 2.91% Portfolio value: 68.3M Avg. open price: N/A Current price: $49.41 P/L: N/A N/A Q3 2022	share	2.91%	68.3M	N/A	$49.41	N/A	N/A Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 2.70% Portfolio value: 63.36M Avg. open price: $4.14 Current price: $10.02 P/L: +141.83% Sold -14.29% shares Q3 2022	share	2.70%	63.36M	$4.14	$10.02	+141.83%	Sold -14.29% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 2.60% Portfolio value: 60.84M Avg. open price: $22.29 Current price: $26.56 P/L: +19.17% Bought +30.30% shares Q3 2022	share	2.60%	60.84M	$22.29	$26.56	+19.17%	Bought +30.30% shares Q3 2022
Biotechnology Scholar Rock Holding Corporation Portfolio share: 2.59% Portfolio value: 60.63M Avg. open price: $14.28 Current price: $7.67 P/L: -46.28% Bought +257.14% shares Q2 2022	share	2.59%	60.63M	$14.28	$7.67	-46.28%	Bought +257.14% shares Q2 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 2.50% Portfolio value: 58.58M Avg. open price: $38.41 Current price: $24.25 P/L: -36.87% Bought +128.16% shares Q3 2022	share	2.50%	58.58M	$38.41	$24.25	-36.87%	Bought +128.16% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 2.49% Portfolio value: 58.26M Avg. open price: $29.25 Current price: $20.4 P/L: -30.26% Bought +30.00% shares Q2 2022	share	2.49%	58.26M	$29.25	$20.4	-30.26%	Bought +30.00% shares Q2 2022
Personal Services WW International, Inc. Portfolio share: 2.49% Portfolio value: 58.23M Avg. open price: N/A Current price: $3.97 P/L: N/A N/A Q3 2019	share	2.49%	58.23M	N/A	$3.97	N/A	N/A Q3 2019
Biotechnology Cerevel Therapeutics Holdings, Inc. Portfolio share: 2.41% Portfolio value: 56.52M Avg. open price: $23.45 Current price: $28.31 P/L: +20.74% Bought +33.33% shares Q3 2022	share	2.41%	56.52M	$23.45	$28.31	+20.74%	Bought +33.33% shares Q3 2022
Biotechnology IGM Biosciences, Inc. Portfolio share: 2.38% Portfolio value: 55.71M Avg. open price: $49.03 Current price: $20.05 P/L: -59.11% Bought +22.50% shares Q3 2022	share	2.38%	55.71M	$49.03	$20.05	-59.11%	Bought +22.50% shares Q3 2022
Biotechnology argenx SE Portfolio share: 2.26% Portfolio value: 52.95M Avg. open price: $177.58 Current price: $393.21 P/L: +121.43% Sold -62.50% shares Q3 2022	share	2.26%	52.95M	$177.58	$393.21	+121.43%	Sold -62.50% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 2.07% Portfolio value: 48.45M Avg. open price: $24.14 Current price: $38.12 P/L: +57.89% Sold -21.57% shares Q3 2022	share	2.07%	48.45M	$24.14	$38.12	+57.89%	Sold -21.57% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 2.04% Portfolio value: 47.89M Avg. open price: $162.92 Current price: $121.22 P/L: -25.60% Sold -33.33% shares Q3 2022	share	2.04%	47.89M	$162.92	$121.22	-25.60%	Sold -33.33% shares Q3 2022
Biotechnology AlloVir, Inc. Portfolio share: 1.88% Portfolio value: 44.00M Avg. open price: $3.9 Current price: $7.22 P/L: +85.13% Bought +140.05% shares Q3 2022	share	1.88%	44.00M	$3.9	$7.22	+85.13%	Bought +140.05% shares Q3 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 1.78% Portfolio value: 41.76M Avg. open price: $12.45 Current price: $12.37 P/L: -0.66% Sold -33.33% shares Q1 2022	share	1.78%	41.76M	$12.45	$12.37	-0.66%	Sold -33.33% shares Q1 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 1.66% Portfolio value: 38.89M Avg. open price: $9.9 Current price: $9.29 P/L: -6.16% Bought +37.63% shares Q3 2022	share	1.66%	38.89M	$9.9	$9.29	-6.16%	Bought +37.63% shares Q3 2022
Biotechnology Seer, Inc. Portfolio share: 1.57% Portfolio value: 36.76M Avg. open price: N/A Current price: $6.8 P/L: N/A Sold -15.00% shares Q3 2021	share	1.57%	36.76M	N/A	$6.8	N/A	Sold -15.00% shares Q3 2021
Biotechnology Krystal Biotech, Inc. Portfolio share: 1.49% Portfolio value: 34.85M Avg. open price: $44.38 Current price: $75.78 P/L: +70.75% Sold -28.57% shares Q1 2022	share	1.49%	34.85M	$44.38	$75.78	+70.75%	Sold -28.57% shares Q1 2022
Biotechnology Kymera Therapeutics, Inc. Portfolio share: 1.39% Portfolio value: 32.65M Avg. open price: $41.89 Current price: $29.11 P/L: -30.51% Bought +50.00% shares Q3 2022	share	1.39%	32.65M	$41.89	$29.11	-30.51%	Bought +50.00% shares Q3 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 1.39% Portfolio value: 32.54M Avg. open price: $21.43 Current price: $18.36 P/L: -14.34% Bought +107.82% shares Q3 2022	share	1.39%	32.54M	$21.43	$18.36	-14.34%	Bought +107.82% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 1.25% Portfolio value: 29.37M Avg. open price: $69.11 Current price: $43.52 P/L: -37.03% Bought +66.67% shares Q3 2022	share	1.25%	29.37M	$69.11	$43.52	-37.03%	Bought +66.67% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 1.20% Portfolio value: 28.11M Avg. open price: N/A Current price: $226.95 P/L: N/A N/A Q3 2022	share	1.20%	28.11M	N/A	$226.95	N/A	N/A Q3 2022
Biotechnology Erasca, Inc. Portfolio share: 1.06% Portfolio value: 24.74M Avg. open price: N/A Current price: $7.28 P/L: N/A N/A Q3 2021	share	1.06%	24.74M	N/A	$7.28	N/A	N/A Q3 2021
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.89% Portfolio value: 20.79M Avg. open price: $2.58 Current price: $12 P/L: +365.12% Bought +103.85% shares Q3 2022	share	0.89%	20.79M	$2.58	$12	+365.12%	Bought +103.85% shares Q3 2022
Biotechnology EQRx, Inc. Portfolio share: 0.84% Portfolio value: 19.8M Avg. open price: N/A Current price: $3.46 P/L: N/A N/A Q4 2021	share	0.84%	19.8M	N/A	$3.46	N/A	N/A Q4 2021
Biotechnology Denali Therapeutics Inc. Portfolio share: 0.79% Portfolio value: 18.41M Avg. open price: $46.14 Current price: $30.94 P/L: -32.94% Bought +20.00% shares Q4 2021	share	0.79%	18.41M	$46.14	$30.94	-32.94%	Bought +20.00% shares Q4 2021
Health Information Services Schrödinger, Inc. Portfolio share: 0.75% Portfolio value: 17.48M Avg. open price: N/A Current price: $16.48 P/L: N/A Sold -12.22% shares Q3 2021	share	0.75%	17.48M	N/A	$16.48	N/A	Sold -12.22% shares Q3 2021
Biotechnology Replimune Group, Inc. Portfolio share: 0.66% Portfolio value: 15.54M Avg. open price: $19.72 Current price: $19.95 P/L: +1.15% Bought +12.50% shares Q2 2021	share	0.66%	15.54M	$19.72	$19.95	+1.15%	Bought +12.50% shares Q2 2021
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.66% Portfolio value: 15.38M Avg. open price: $38.39 Current price: $42.01 P/L: +9.43% Bought +10.00% shares Q3 2021	share	0.66%	15.38M	$38.39	$42.01	+9.43%	Bought +10.00% shares Q3 2021
Biotechnology Kura Oncology, Inc. Portfolio share: 0.64% Portfolio value: 15.02M Avg. open price: $18.1 Current price: $15.82 P/L: -12.58% Bought +4.76% shares Q3 2022	share	0.64%	15.02M	$18.1	$15.82	-12.58%	Bought +4.76% shares Q3 2022
Biotechnology Generation Bio Co. Portfolio share: 0.64% Portfolio value: 14.94M Avg. open price: N/A Current price: $5.22 P/L: N/A N/A Q2 2020	share	0.64%	14.94M	N/A	$5.22	N/A	N/A Q2 2020
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 0.63% Portfolio value: 14.87M Avg. open price: $10.57 Current price: $7.05 P/L: -33.33% Bought +83.33% shares Q1 2022	share	0.63%	14.87M	$10.57	$7.05	-33.33%	Bought +83.33% shares Q1 2022
Biotechnology Foghorn Therapeutics Inc. Portfolio share: 0.63% Portfolio value: 14.76M Avg. open price: N/A Current price: $6.73 P/L: N/A N/A Q4 2020	share	0.63%	14.76M	N/A	$6.73	N/A	N/A Q4 2020
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.59% Portfolio value: 13.74M Avg. open price: N/A Current price: $21.42 P/L: N/A Sold -20.00% shares Q3 2021	share	0.59%	13.74M	N/A	$21.42	N/A	Sold -20.00% shares Q3 2021
Biotechnology Seagen Inc. Portfolio share: 0.58% Portfolio value: 13.68M Avg. open price: $162.92 Current price: $121.22 P/L: -25.60% N/A Q3 2022	call	0.58%	13.68M	$162.92	$121.22	-25.60%	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.57% Portfolio value: 13.45M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	share	0.57%	13.45M	N/A	$21.89	N/A	N/A Q3 2022
Biotechnology Omega Therapeutics, Inc. Portfolio share: 0.53% Portfolio value: 12.32M Avg. open price: N/A Current price: $6.77 P/L: N/A N/A Q3 2021	share	0.53%	12.32M	N/A	$6.77	N/A	N/A Q3 2021
Biotechnology Wave Life Sciences Ltd. Portfolio share: 0.46% Portfolio value: 10.83M Avg. open price: $2.93 Current price: $4.25 P/L: +44.97% Bought +200.00% shares Q2 2022	share	0.46%	10.83M	$2.93	$4.25	+44.97%	Bought +200.00% shares Q2 2022
Drug Manufacturers—Specialty & Generic Evotec SE Portfolio share: 0.43% Portfolio value: 10.10M Avg. open price: N/A Current price: $8.76 P/L: N/A N/A Q4 2021	share	0.43%	10.10M	N/A	$8.76	N/A	N/A Q4 2021
Internet Retail Sea Limited Portfolio share: 0.41% Portfolio value: 9.66M Avg. open price: $66.86 Current price: $59.02 P/L: -11.73% Bought +200.00% shares Q3 2022	share	0.41%	9.66M	$66.86	$59.02	-11.73%	Bought +200.00% shares Q3 2022
Biotechnology Syros Pharmaceuticals, Inc. Portfolio share: 0.40% Portfolio value: 9.42M Avg. open price: $5.35 Current price: $3.83 P/L: -28.37% N/A Q3 2022	share	0.40%	9.42M	$5.35	$3.83	-28.37%	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.38% Portfolio value: 8.97M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	call	0.38%	8.97M	N/A	$21.89	N/A	N/A Q3 2022
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 0.37% Portfolio value: 8.59M Avg. open price: $8.51 Current price: $6.78 P/L: -20.39% Bought +101.18% shares Q3 2022	share	0.37%	8.59M	$8.51	$6.78	-20.39%	Bought +101.18% shares Q3 2022
Biotechnology Repare Therapeutics Inc. Portfolio share: 0.36% Portfolio value: 8.49M Avg. open price: $26.24 Current price: $16.49 P/L: -37.16% Bought +27.27% shares Q4 2021	share	0.36%	8.49M	$26.24	$16.49	-37.16%	Bought +27.27% shares Q4 2021
Biotechnology AGENUS INC Portfolio share: 0.35% Portfolio value: 8.2M Avg. open price: $4.17 Current price: $2.79 P/L: -33.20% Bought +33.33% shares Q3 2022	share	0.35%	8.2M	$4.17	$2.79	-33.20%	Bought +33.33% shares Q3 2022
Biotechnology Selecta Biosciences, Inc. Portfolio share: 0.34% Portfolio value: 8.00M Avg. open price: $2.97 Current price: $1.31 P/L: -55.92% Bought +22.08% shares Q2 2022	share	0.34%	8.00M	$2.97	$1.31	-55.92%	Bought +22.08% shares Q2 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 0.33% Portfolio value: 7.62M Avg. open price: N/A Current price: $20.04 P/L: N/A Sold -26.48% shares Q1 2022	share	0.33%	7.62M	N/A	$20.04	N/A	Sold -26.48% shares Q1 2022
Biotechnology Aurinia Pharmaceuticals Inc. Portfolio share: 0.32% Portfolio value: 7.52M Avg. open price: $15.21 Current price: $4.91 P/L: -67.71% Bought +11.11% shares Q3 2020	share	0.32%	7.52M	$15.21	$4.91	-67.71%	Bought +11.11% shares Q3 2020
Shell Companies Omega Alpha SPAC Portfolio share: 0.32% Portfolio value: 7.44M Avg. open price: N/A Current price: $10.06 P/L: N/A N/A Q1 2021	share	0.32%	7.44M	N/A	$10.06	N/A	N/A Q1 2021
Biotechnology BeiGene, Ltd. Portfolio share: 0.29% Portfolio value: 6.74M Avg. open price: $134.98 Current price: $188.71 P/L: +39.80% N/A Q3 2022	call	0.29%	6.74M	$134.98	$188.71	+39.80%	N/A Q3 2022
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 0.28% Portfolio value: 6.66M Avg. open price: $21 Current price: $11.47 P/L: -45.38% Bought +75.00% shares Q1 2021	share	0.28%	6.66M	$21	$11.47	-45.38%	Bought +75.00% shares Q1 2021
Biotechnology Y-mAbs Therapeutics, Inc. Portfolio share: 0.25% Portfolio value: 5.76M Avg. open price: $49.51 Current price: $4.43 P/L: -91.05% Bought +40.34% shares Q1 2021	share	0.25%	5.76M	$49.51	$4.43	-91.05%	Bought +40.34% shares Q1 2021
Biotechnology Ikena Oncology, Inc. Portfolio share: 0.23% Portfolio value: 5.50M Avg. open price: N/A Current price: $2.23 P/L: N/A N/A Q1 2021	share	0.23%	5.50M	N/A	$2.23	N/A	N/A Q1 2021
Biotechnology Talaris Therapeutics, Inc. Portfolio share: 0.23% Portfolio value: 5.42M Avg. open price: N/A Current price: $1.42 P/L: N/A N/A Q2 2021	share	0.23%	5.42M	N/A	$1.42	N/A	N/A Q2 2021
Biotechnology Kronos Bio, Inc. Portfolio share: 0.22% Portfolio value: 5.16M Avg. open price: $20.96 Current price: $1.77 P/L: -91.56% Bought +17.07% shares Q4 2021	share	0.22%	5.16M	$20.96	$1.77	-91.56%	Bought +17.07% shares Q4 2021
Biotechnology Lyell Immunopharma, Inc. Portfolio share: 0.22% Portfolio value: 5.13M Avg. open price: N/A Current price: $3.93 P/L: N/A N/A Q2 2021	share	0.22%	5.13M	N/A	$3.93	N/A	N/A Q2 2021
Biotechnology Achilles Therapeutics plc Portfolio share: 0.22% Portfolio value: 5.09M Avg. open price: N/A Current price: $1.71 P/L: N/A N/A Q1 2021	share	0.22%	5.09M	N/A	$1.71	N/A	N/A Q1 2021
Biotechnology Recursion Pharmaceuticals, Inc. Portfolio share: 0.20% Portfolio value: 4.78M Avg. open price: $17.48 Current price: $9.11 P/L: -47.88% Bought +125.00% shares Q1 2022	share	0.20%	4.78M	$17.48	$9.11	-47.88%	Bought +125.00% shares Q1 2022
Biotechnology ALX Oncology Holdings Inc. Portfolio share: 0.20% Portfolio value: 4.78M Avg. open price: $63.4 Current price: $11.92 P/L: -81.20% Sold -4.76% shares Q2 2021	share	0.20%	4.78M	$63.4	$11.92	-81.20%	Sold -4.76% shares Q2 2021
Biotechnology Ovid Therapeutics Inc. Portfolio share: 0.20% Portfolio value: 4.6M Avg. open price: N/A Current price: $1.79 P/L: N/A N/A Q3 2020	share	0.20%	4.6M	N/A	$1.79	N/A	N/A Q3 2020
Biotechnology Exscientia plc Portfolio share: 0.19% Portfolio value: 4.51M Avg. open price: N/A Current price: $5.51 P/L: N/A N/A Q4 2021	share	0.19%	4.51M	N/A	$5.51	N/A	N/A Q4 2021
Diagnostics & Research Natera, Inc. Portfolio share: 0.19% Portfolio value: 4.38M Avg. open price: N/A Current price: $40.39 P/L: N/A N/A Q3 2022	share	0.19%	4.38M	N/A	$40.39	N/A	N/A Q3 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 0.17% Portfolio value: 4.08M Avg. open price: $24.63 Current price: $11.18 P/L: -54.61% Bought +75.44% shares Q4 2021	share	0.17%	4.08M	$24.63	$11.18	-54.61%	Bought +75.44% shares Q4 2021
Beverages—Non-Alcoholic Oatly Group AB Portfolio share: 0.17% Portfolio value: 3.94M Avg. open price: N/A Current price: $1.54 P/L: N/A N/A Q2 2021	share	0.17%	3.94M	N/A	$1.54	N/A	N/A Q2 2021
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 0.16% Portfolio value: 3.84M Avg. open price: N/A Current price: $4.76 P/L: N/A N/A Q3 2022	share	0.16%	3.84M	N/A	$4.76	N/A	N/A Q3 2022
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 0.16% Portfolio value: 3.79M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	0.16%	3.79M	N/A	$22	N/A	N/A Q3 2022
Specialty Industrial Machinery Mirion Technologies, Inc. Portfolio share: 0.16% Portfolio value: 3.73M Avg. open price: N/A Current price: $6.18 P/L: N/A N/A Q4 2021	share	0.16%	3.73M	N/A	$6.18	N/A	N/A Q4 2021
Shell Companies Portage Fintech Acquisition Corporation Portfolio share: 0.16% Portfolio value: 3.71M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q3 2021	share	0.16%	3.71M	N/A	$10	N/A	N/A Q3 2021
Biotechnology SQZ Biotechnologies Company Portfolio share: 0.16% Portfolio value: 3.66M Avg. open price: $28.98 Current price: $1.41 P/L: -95.13% Bought 0.00% shares Q1 2021	share	0.16%	3.66M	$28.98	$1.41	-95.13%	Bought 0.00% shares Q1 2021
Biotechnology Nanobiotix S.A. Portfolio share: 0.15% Portfolio value: 3.54M Avg. open price: N/A Current price: $3.83 P/L: N/A N/A Q4 2020	share	0.15%	3.54M	N/A	$3.83	N/A	N/A Q4 2020
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.15% Portfolio value: 3.52M Avg. open price: $1.61 Current price: $0.52 P/L: -67.90% Bought +33.33% shares Q3 2021	share	0.15%	3.52M	$1.61	$0.52	-67.90%	Bought +33.33% shares Q3 2021
Biotechnology I-Mab Portfolio share: 0.15% Portfolio value: 3.40M Avg. open price: $40.47 Current price: $3.71 P/L: -90.83% Bought +3.03% shares Q4 2021	share	0.15%	3.40M	$40.47	$3.71	-90.83%	Bought +3.03% shares Q4 2021
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 3.21M Avg. open price: $22.9 Current price: $7.16 P/L: -68.73% Sold -7.66% shares Q4 2020	share	0.14%	3.21M	$22.9	$7.16	-68.73%	Sold -7.66% shares Q4 2020
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.14% Portfolio value: 3.20M Avg. open price: $22.57 Current price: $11.61 P/L: -48.56% Bought +150.00% shares Q4 2021	share	0.14%	3.20M	$22.57	$11.61	-48.56%	Bought +150.00% shares Q4 2021
Biotechnology AC Immune SA Portfolio share: 0.13% Portfolio value: 3.16M Avg. open price: $11.6 Current price: $2.42 P/L: -79.13% Bought +1.57% shares Q3 2020	share	0.13%	3.16M	$11.6	$2.42	-79.13%	Bought +1.57% shares Q3 2020
Biotechnology Black Diamond Therapeutics, Inc. Portfolio share: 0.12% Portfolio value: 2.78M Avg. open price: $30.23 Current price: $1.86 P/L: -93.85% Bought +8.22% shares Q4 2020	share	0.12%	2.78M	$30.23	$1.86	-93.85%	Bought +8.22% shares Q4 2020
Biotechnology Zymeworks Inc. Portfolio share: 0.12% Portfolio value: 2.76M Avg. open price: $47.26 Current price: $7.62 P/L: -83.88% Bought +28.57% shares Q1 2021	share	0.12%	2.76M	$47.26	$7.62	-83.88%	Bought +28.57% shares Q1 2021
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 0.12% Portfolio value: 2.72M Avg. open price: $32.76 Current price: $2.14 P/L: -93.47% Bought +60.00% shares Q2 2021	share	0.12%	2.72M	$32.76	$2.14	-93.47%	Bought +60.00% shares Q2 2021
Biotechnology BridgeBio Pharma, Inc. Portfolio share: 0.11% Portfolio value: 2.48M Avg. open price: $35.9 Current price: $9.17 P/L: -74.46% Sold -9.09% shares Q3 2021	share	0.11%	2.48M	$35.9	$9.17	-74.46%	Sold -9.09% shares Q3 2021
Biotechnology HOOKIPA Pharma Inc. Portfolio share: 0.11% Portfolio value: 2.47M Avg. open price: $3.99 Current price: $0.95 P/L: -76.21% Bought +208.47% shares Q1 2022	share	0.11%	2.47M	$3.99	$0.95	-76.21%	Bought +208.47% shares Q1 2022
Biotechnology Sana Biotechnology, Inc. Portfolio share: 0.10% Portfolio value: 2.4M Avg. open price: N/A Current price: $4.35 P/L: N/A N/A Q1 2021	share	0.10%	2.4M	N/A	$4.35	N/A	N/A Q1 2021
Biotechnology CYCLERION THERAPEUTICS INC Portfolio share: 0.10% Portfolio value: 2.39M Avg. open price: $2.77 Current price: $0.82 P/L: -70.36% Bought +52.90% shares Q2 2021	share	0.10%	2.39M	$2.77	$0.82	-70.36%	Bought +52.90% shares Q2 2021
Biotechnology Ambrx Biopharma Inc. Portfolio share: 0.10% Portfolio value: 2.32M Avg. open price: $13.5 Current price: $0.52 P/L: -96.15% Bought +153.21% shares Q4 2021	share	0.10%	2.32M	$13.5	$0.52	-96.15%	Bought +153.21% shares Q4 2021
Biotechnology Minerva Neurosciences, Inc. Portfolio share: 0.10% Portfolio value: 2.30M Avg. open price: $10.19 Current price: $3.32 P/L: -67.41% N/A Q3 2022	share	0.10%	2.30M	$10.19	$3.32	-67.41%	N/A Q3 2022
Biotechnology Senti Biosciences, Inc. Portfolio share: 0.10% Portfolio value: 2.29M Avg. open price: N/A Current price: $2.09 P/L: N/A N/A Q2 2022	share	0.10%	2.29M	N/A	$2.09	N/A	N/A Q2 2022
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.10% Portfolio value: 2.25M Avg. open price: $10.72 Current price: $2.36 P/L: -77.99% Bought +39.08% shares Q2 2021	share	0.10%	2.25M	$10.72	$2.36	-77.99%	Bought +39.08% shares Q2 2021
Biotechnology Aptinyx Inc. Portfolio share: 0.10% Portfolio value: 2.25M Avg. open price: $3.44 Current price: $0.25 P/L: -92.65% Bought +144.46% shares Q1 2021	share	0.10%	2.25M	$3.44	$0.25	-92.65%	Bought +144.46% shares Q1 2021
Biotechnology Graphite Bio, Inc. Portfolio share: 0.09% Portfolio value: 2.21M Avg. open price: N/A Current price: $3.59 P/L: N/A N/A Q2 2021	share	0.09%	2.21M	N/A	$3.59	N/A	N/A Q2 2021
Biotechnology Immunic, Inc. Portfolio share: 0.09% Portfolio value: 2.21M Avg. open price: $12.12 Current price: $1.34 P/L: -88.94% Sold -12.50% shares Q4 2020	share	0.09%	2.21M	$12.12	$1.34	-88.94%	Sold -12.50% shares Q4 2020
Biotechnology Vor Biopharma Inc. Portfolio share: 0.09% Portfolio value: 2.18M Avg. open price: N/A Current price: $4.72 P/L: N/A N/A Q1 2021	share	0.09%	2.18M	N/A	$4.72	N/A	N/A Q1 2021
Biotechnology Instil Bio, Inc. Portfolio share: 0.09% Portfolio value: 2.17M Avg. open price: N/A Current price: $1.22 P/L: N/A N/A Q1 2021	share	0.09%	2.17M	N/A	$1.22	N/A	N/A Q1 2021
Biotechnology Taysha Gene Therapies, Inc. Portfolio share: 0.09% Portfolio value: 2.00M Avg. open price: N/A Current price: $2.29 P/L: N/A Sold -8.77% shares Q4 2020	share	0.09%	2.00M	N/A	$2.29	N/A	Sold -8.77% shares Q4 2020
Biotechnology Gritstone bio, Inc. Portfolio share: 0.08% Portfolio value: 1.92M Avg. open price: $13.3 Current price: $2.87 P/L: -78.42% N/A Q4 2021	share	0.08%	1.92M	$13.3	$2.87	-78.42%	N/A Q4 2021
Diagnostics & Research 23andMe Holding Co. Portfolio share: 0.08% Portfolio value: 1.89M Avg. open price: N/A Current price: $3.19 P/L: N/A N/A Q4 2021	share	0.08%	1.89M	N/A	$3.19	N/A	N/A Q4 2021
Pharmaceutical Retailers 111, Inc. Portfolio share: 0.08% Portfolio value: 1.84M Avg. open price: $5.97 Current price: $2.82 P/L: -52.74% Sold -28.97% shares Q3 2022	share	0.08%	1.84M	$5.97	$2.82	-52.74%	Sold -28.97% shares Q3 2022
Biotechnology Immutep Limited Portfolio share: 0.07% Portfolio value: 1.56M Avg. open price: N/A Current price: $2.24 P/L: N/A N/A Q2 2021	share	0.07%	1.56M	N/A	$2.24	N/A	N/A Q2 2021
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.06% Portfolio value: 1.49M Avg. open price: N/A Current price: $7.05 P/L: N/A N/A Q4 2020	share	0.06%	1.49M	N/A	$7.05	N/A	N/A Q4 2020
Biotechnology Solid Biosciences Inc. Portfolio share: 0.06% Portfolio value: 1.4M Avg. open price: $16.14 Current price: $6.46 P/L: -59.97% Bought +33.33% shares Q3 2021	share	0.06%	1.4M	$16.14	$6.46	-59.97%	Bought +33.33% shares Q3 2021
Biotechnology TCR2 Therapeutics Inc. Portfolio share: 0.06% Portfolio value: 1.35M Avg. open price: $25.09 Current price: $1.37 P/L: -94.54% Bought +50.00% shares Q1 2021	share	0.06%	1.35M	$25.09	$1.37	-94.54%	Bought +50.00% shares Q1 2021
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 1.31M Avg. open price: N/A Current price: $2.43 P/L: N/A N/A Q4 2021	share	0.06%	1.31M	N/A	$2.43	N/A	N/A Q4 2021
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.06% Portfolio value: 1.29M Avg. open price: N/A Current price: $0.83 P/L: N/A N/A Q1 2021	share	0.06%	1.29M	N/A	$0.83	N/A	N/A Q1 2021
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 0.05% Portfolio value: 1.28M Avg. open price: $24.5 Current price: $4.02 P/L: -83.59% Bought +300.00% shares Q2 2021	share	0.05%	1.28M	$24.5	$4.02	-83.59%	Bought +300.00% shares Q2 2021
Biotechnology Adagene Inc. Portfolio share: 0.05% Portfolio value: 1.28M Avg. open price: $17.95 Current price: $1.09 P/L: -93.93% Bought +25.00% shares Q2 2021	share	0.05%	1.28M	$17.95	$1.09	-93.93%	Bought +25.00% shares Q2 2021
Biotechnology Axcella Health Inc. Portfolio share: 0.05% Portfolio value: 1.21M Avg. open price: $4.29 Current price: $0.9 P/L: -79.00% Sold -20.83% shares Q3 2020	share	0.05%	1.21M	$4.29	$0.9	-79.00%	Sold -20.83% shares Q3 2020
Biotechnology Cardiff Oncology, Inc. Portfolio share: 0.05% Portfolio value: 1.15M Avg. open price: N/A Current price: $1.56 P/L: N/A Sold -16.67% shares Q1 2021	share	0.05%	1.15M	N/A	$1.56	N/A	Sold -16.67% shares Q1 2021
Drug Manufacturers—Specialty & Generic Ironwood Pharmaceuticals, Inc. Portfolio share: 0.05% Portfolio value: 1.14M Avg. open price: $16.57 Current price: $12 P/L: -27.57% Sold -49.04% shares Q3 2018	share	0.05%	1.14M	$16.57	$12	-27.57%	Sold -49.04% shares Q3 2018
Biotechnology IGM Biosciences, Inc. Portfolio share: 0.05% Portfolio value: 1.13M Avg. open price: $49.03 Current price: $20.05 P/L: -59.11% N/A Q2 2022	call	0.05%	1.13M	$49.03	$20.05	-59.11%	N/A Q2 2022
Biotechnology Caribou Biosciences, Inc. Portfolio share: 0.05% Portfolio value: 1.11M Avg. open price: N/A Current price: $9.14 P/L: N/A Sold -74.01% shares Q1 2022	share	0.05%	1.11M	N/A	$9.14	N/A	Sold -74.01% shares Q1 2022
Biotechnology Aravive, Inc. Portfolio share: 0.05% Portfolio value: 1.07M Avg. open price: $7.88 Current price: $1.49 P/L: -81.16% Sold -5.00% shares Q3 2020	share	0.05%	1.07M	$7.88	$1.49	-81.16%	Sold -5.00% shares Q3 2020
Biotechnology Marinus Pharmaceuticals, Inc. Portfolio share: 0.04% Portfolio value: 1.04M Avg. open price: $15.02 Current price: $4.63 P/L: -69.18% Sold -84.30% shares Q3 2022	share	0.04%	1.04M	$15.02	$4.63	-69.18%	Sold -84.30% shares Q3 2022
Biotechnology Spero Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 1M Avg. open price: $13.5 Current price: $1.89 P/L: -86.00% Sold -16.67% shares Q4 2020	share	0.04%	1M	$13.5	$1.89	-86.00%	Sold -16.67% shares Q4 2020
Biotechnology Harpoon Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 970K Avg. open price: $15.45 Current price: $0.72 P/L: -95.34% Bought +25.00% shares Q1 2021	share	0.04%	970K	$15.45	$0.72	-95.34%	Bought +25.00% shares Q1 2021
Biotechnology LAVA Therapeutics N.V. Portfolio share: 0.04% Portfolio value: 914K Avg. open price: N/A Current price: $6.17 P/L: N/A N/A Q1 2021	share	0.04%	914K	N/A	$6.17	N/A	N/A Q1 2021
Biotechnology Curis, Inc. Portfolio share: 0.04% Portfolio value: 910K Avg. open price: $1.17 Current price: $0.77 P/L: -33.93% Sold -27.97% shares Q2 2021	share	0.04%	910K	$1.17	$0.77	-33.93%	Sold -27.97% shares Q2 2021
Biotechnology Orchard Therapeutics plc Portfolio share: 0.04% Portfolio value: 902K Avg. open price: $4.63 Current price: $0.45 P/L: -90.29% Bought +413.19% shares Q1 2021	share	0.04%	902K	$4.63	$0.45	-90.29%	Bought +413.19% shares Q1 2021
Biotechnology Rubius Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 886K Avg. open price: $8.52 Current price: $0.19 P/L: -97.81% Sold -44.82% shares Q3 2022	share	0.04%	886K	$8.52	$0.19	-97.81%	Sold -44.82% shares Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 0.04% Portfolio value: 882K Avg. open price: N/A Current price: $22.35 P/L: N/A N/A Q3 2022	share	0.04%	882K	N/A	$22.35	N/A	N/A Q3 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.03% Portfolio value: 719K Avg. open price: N/A Current price: $2.79 P/L: N/A N/A Q4 2020	share	0.03%	719K	N/A	$2.79	N/A	N/A Q4 2020
Biotechnology NexImmune, Inc. Portfolio share: 0.03% Portfolio value: 666K Avg. open price: N/A Current price: $0.41 P/L: N/A N/A Q1 2021	share	0.03%	666K	N/A	$0.41	N/A	N/A Q1 2021
Biotechnology MiNK Therapeutics, Inc. Portfolio share: 0.03% Portfolio value: 611K Avg. open price: N/A Current price: $2.54 P/L: N/A N/A Q4 2021	share	0.03%	611K	N/A	$2.54	N/A	N/A Q4 2021
Biotechnology Metacrine, Inc. Portfolio share: 0.02% Portfolio value: 449K Avg. open price: N/A Current price: $0.41 P/L: N/A Sold -29.37% shares Q4 2020	share	0.02%	449K	N/A	$0.41	N/A	Sold -29.37% shares Q4 2020
Insurance—Specialty Hippo Holdings Inc. Portfolio share: 0.02% Portfolio value: 445K Avg. open price: N/A Current price: $13.87 P/L: N/A N/A Q3 2022	share	0.02%	445K	N/A	$13.87	N/A	N/A Q3 2022
Biotechnology Corvus Pharmaceuticals, Inc. Portfolio share: 0.02% Portfolio value: 409K Avg. open price: N/A Current price: $1 P/L: N/A N/A Q3 2021	share	0.02%	409K	N/A	$1	N/A	N/A Q3 2021
Biotechnology MEI Pharma, Inc. Portfolio share: 0.02% Portfolio value: 387K Avg. open price: $3.54 Current price: $0.39 P/L: -88.96% Bought +31.58% shares Q2 2021	share	0.02%	387K	$3.54	$0.39	-88.96%	Bought +31.58% shares Q2 2021
Biotechnology Applied Therapeutics, Inc. Portfolio share: 0.02% Portfolio value: 372K Avg. open price: $22.01 Current price: $0.9 P/L: -95.91% Bought +5.26% shares Q1 2021	share	0.02%	372K	$22.01	$0.9	-95.91%	Bought +5.26% shares Q1 2021
Software—Infrastructure Adobe Inc. Portfolio share: 0.02% Portfolio value: 358K Avg. open price: N/A Current price: $334.28 P/L: N/A N/A Q3 2022	share	0.02%	358K	N/A	$334.28	N/A	N/A Q3 2022
Biotechnology Yumanity Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 341K Avg. open price: N/A Current price: $2.05 P/L: N/A N/A Q4 2020	share	0.01%	341K	N/A	$2.05	N/A	N/A Q4 2020
Biotechnology Astria Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 301K Avg. open price: N/A Current price: $10.32 P/L: N/A N/A Q3 2021	share	0.01%	301K	N/A	$10.32	N/A	N/A Q3 2021
Biotechnology ContraFect Corporation Portfolio share: 0.01% Portfolio value: 252K Avg. open price: $5.05 Current price: $0.14 P/L: -97.17% Bought +50.00% shares Q1 2021	share	0.01%	252K	$5.05	$0.14	-97.17%	Bought +50.00% shares Q1 2021
Biotechnology Codiak BioSciences, Inc. Portfolio share: 0.01% Portfolio value: 156K Avg. open price: N/A Current price: $0.67 P/L: N/A N/A Q1 2021	share	0.01%	156K	N/A	$0.67	N/A	N/A Q1 2021
Biotechnology Cidara Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 141K Avg. open price: N/A Current price: $0.6 P/L: N/A Sold -5.00% shares Q3 2020	share	0.01%	141K	N/A	$0.6	N/A	Sold -5.00% shares Q3 2020
Biotechnology Sigilon Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 139K Avg. open price: N/A Current price: $0.41 P/L: N/A N/A Q4 2020	share	0.01%	139K	N/A	$0.41	N/A	N/A Q4 2020
Insurance—Specialty Hippo Holdings Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $13.87 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$13.87	N/A	Sold -100.00% shares Q3 2022
Specialty Retail Bath & Body Works, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $43.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$43.83	N/A	Sold -100.00% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $38.55 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$38.55	N/A	Sold -100.00% shares Q3 2022
Biotechnology Syros Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $5.35 Current price: $3.83 P/L: -28.37% Sold -100.00% shares Q3 2022	share	0.00%	0	$5.35	$3.83	-28.37%	Sold -100.00% shares Q3 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $12.33 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$12.33	N/A	Sold -100.00% shares Q3 2022
Banks—Diversified Citigroup Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $60.84 Current price: $45.64 P/L: -24.99% Sold -100.00% shares Q3 2022	call	0.00%	0	$60.84	$45.64	-24.99%	Sold -100.00% shares Q3 2022
Steel Cleveland-Cliffs Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $15.78 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$15.78	N/A	Sold -100.00% shares Q3 2022
United States Natural Gas Fund, LP Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $17.1 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$17.1	N/A	Sold -100.00% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $88.68 Current price: $226.4 P/L: +155.30% Sold -100.00% shares Q3 2022	share	0.00%	0	$88.68	$226.4	+155.30%	Sold -100.00% shares Q3 2022
Biotechnology Adverum Biotechnologies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $13.94 Current price: $0.66 P/L: -95.27% Sold -100.00% shares Q3 2022	share	0.00%	0	$13.94	$0.66	-95.27%	Sold -100.00% shares Q3 2022
Biotechnology Adagio Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $4.64 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$4.64	N/A	Sold -100.00% shares Q3 2022
Biotechnology Kaleido Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0	N/A	Sold -100.00% shares Q3 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $13.67 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$13.67	N/A	Sold -100.00% shares Q3 2022
Direxion Daily S&P Biotech Bull 3X Shares Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.27 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$7.27	N/A	Sold -100.00% shares Q3 2022
Biotechnology Atara Biotherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.46 Current price: $4.65 P/L: -73.37% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.46	$4.65	-73.37%	Sold -100.00% shares Q3 2022

Showing TOP 150 ARTAL GROUP S.A.'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ARTAL GROUP S.A.?

The biggest position of the ARTAL GROUP S.A. is SPDR S&P Biotech ETF (XBI) with 16.93% portfolio share worth of 396.6M US dollars.

Top 5 ARTAL GROUP S.A.'s holdings represent 36.73% of the portfolio:

SPDR S&P Biotech ETF (XBI) – 16.93%
Lexicon Pharmaceuticals, Inc. (LXRX) – 9.2%
Mirati Therapeutics, Inc. (MRTX) – 3.95%
BeiGene, Ltd. (BGNE) – 3.74%
Apellis Pharmaceuticals, Inc. (APLS) – 2.91%

Who is the portfolio manager of ARTAL GROUP S.A.?

The portfolio manager of the ARTAL GROUP S.A. is .

What is the total asset value of the ARTAL GROUP S.A. portfolio?

ARTAL GROUP S.A. total asset value (portfolio value) is 2.34B US dollars.

Who is ?

is the portfolio manager of the ARTAL GROUP S.A..

What is (ARTAL GROUP S.A.) fund performance?

ARTAL GROUP S.A.'s quarterly performance is +2.53%, annualy -53.83%. In the past 3 years, the value of 's portfolio has decreased by -49%. In the past 5 years, the value of the portfolio has decreased by -25%.

What is the ARTAL GROUP S.A. CIK?

ARTAL GROUP S.A.'s Central Index Key is 0001053906 .

ARTAL GROUP S.A. Holdings

ARTAL GROUP S.A. portfolio value:

ARTAL GROUP S.A. quarter portfolio value change:

ARTAL GROUP S.A. 1 year portfolio value change:

ARTAL GROUP S.A. 3 years portfolio value change:

ARTAL GROUP S.A. 5 years portfolio value change: